Comparing PharmaCyte Biotech (NASDAQ:PMCB) & Kiromic BioPharma (NASDAQ:KRBP)
Insider and Institutional Ownership 34.2% of PharmaCyte Biotech shares are owned by institutional investors. Comparatively, 10.9% of Kiromic BioPharma shares are owned by institutional investors. 10.2% of PharmaCyte Biotech shares are owned by insiders. Comparatively, 20.6% of Kiromic BioPharma shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers […]
